Nonmuscle invasive bladder cancer
Conditions
Interventions
Experimental Group:Intravesical perfusion of plasma-activated normal saline
Sponsors
The First Affiliated Hospital of Air Force Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Those with a pathological diagnosis of non-muscle-invasive bladder urothelial carcinoma. 2. Those without lymph node or distant metastasis confirmed by imaging examinations.
Exclusion criteria
Exclusion criteria: 1. It is known or possible that a bladder tumor has metastasized from another organ; 2. Patients who cannot tolerate or are not suitable for TURBT; 3. Patients in the acute infection stage or with systemic infection; 4. Suffering from other tumors; 5. Patients who have previously received intravesical treatment; 6. Patients with severe coagulation dysfunction or insufficiency of vital organs such as the heart, brain and lungs; 7. Patients who did not have regular follow-up visits or follow-ups after surgery and have lost contact.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of dose-limiting toxicity; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of dose-limiting toxicity; | — |
Countries
China
Contacts
Public ContactYang Xiaojian
The First Affiliated Hospital of Air Force Medical University
Outcome results
None listed